B3GALT6
Summary: The enzyme encoded by this intronless gene is a beta-1,3-galactosyltransferase found in the medial Golgi apparatus, where it catalyzes the transfer of galactose from UDP-galactose to substrates containing a terminal beta-linked galactose moiety. The encoded enzyme has a particular affinity for galactose-beta-1,4-xylose found in the linker region of glycosamines. This enzyme is required for glycosaminoglycan synthesis. [provided by RefSeq, Jun 2013].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
beta-1,3-galactosyltransferase 6 | MIM:615291 | Ensembl:ENSG00000176022 | HGNC:HGNC:17978 | PA25214 | 1p36.33 |
GO terms in B3GALT6
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IBA | GO:0008378 | galactosyltransferase activity |
MF | IEA | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
MF | IBA | GO:0016758 | transferase activity, transferring hexosyl groups |
MF | IBA | GO:0035250 | UDP-galactosyltransferase activity |
MF | IDA | GO:0035250 | UDP-galactosyltransferase activity |
MF | TAS | GO:0047220 | galactosylxylosylprotein 3-beta-galactosyltransferase activity |
BP | IBA | GO:0006024 | glycosaminoglycan biosynthetic process |
BP | IMP | GO:0006024 | glycosaminoglycan biosynthetic process |
BP | IBA | GO:0006486 | protein glycosylation |
BP | IEA | GO:0006486 | protein glycosylation |
BP | IEA | GO:0015012 | heparan sulfate proteoglycan biosynthetic process |
BP | TAS | GO:0030203 | glycosaminoglycan metabolic process |
BP | IEA | GO:0030206 | chondroitin sulfate biosynthetic process |
CC | TAS | GO:0000139 | Golgi membrane |
CC | IBA | GO:0005783 | endoplasmic reticulum |
CC | IBA | GO:0005794 | Golgi apparatus |
CC | IDA | GO:0005797 | Golgi medial cisterna |
CC | HDA | GO:0016020 | membrane |
CC | IBA | GO:0016020 | membrane |
CC | IEA | GO:0016021 | integral component of membrane |
CC | IEA | GO:0032580 | Golgi cisterna membrane |
Gene expression in normal tissue: B3GALT6
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in B3GALT6
Database | Pathway ID | Pathway Des. |
---|---|---|
humancyc | PWY-6557 | glycoaminoglycan-protein linkage region biosynthesis |
humancyc | PWY-6564 | heparan sulfate biosynthesis |
humancyc | PWY-6569 | chondroitin sulfate biosynthesis |
humancyc | PWY-6571 | dermatan sulfate biosynthesis |
kegg | hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate - Homo sapiens (human) |
kegg | hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human) |
reactome | R-HSA-1430728 | Metabolism |
reactome | R-HSA-1630316 | Glycosaminoglycan metabolism |
reactome | R-HSA-1638091 | Heparan sulfate/heparin (HS-GAG) metabolism |
reactome | R-HSA-1643685 | Disease |
reactome | R-HSA-1793185 | Chondroitin sulfate/dermatan sulfate metabolism |
reactome | R-HSA-1971475 | A tetrasaccharide linker sequence is required for GAG synthesis |
reactome | R-HSA-3560782 | Diseases associated with glycosaminoglycan metabolism |
reactome | R-HSA-3781865 | Diseases of glycosylation |
reactome | R-HSA-4420332 | Defective B3GALT6 causes EDSP2 and SEMDJL1 |
reactome | R-HSA-71387 | Metabolism of carbohydrates |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD679 | Bistramide A | 2 |
iGMDRD394 | BX-795 | 2 |
iGMDRD466 | Chaetocin | 2 |
iGMDRD280 | CYTOCHALASIN B | 6 |
iGMDRD781 | Sirolimus | 5 |
iGMDRD427 | ABT737 | 1 |
iGMDRD424 | Tamatinib | 1 |
iGMDRD577 | BIX01294 | 2 |
iGMDRD780 | PP-30 | 2 |
iGMDRD366 | PI-103 | 2 |
iGMDRD562 | Navitoclax | 7 |
iGMDRD286 | Nsc 632839 | 1 |
iGMDRD188 | Piperlongumine | 2 |
iGMDRD882 | CIL41 | 2 |
iGMDRD886 | Compound 1541A | 2 |
iGMDRD60 | Quinoclamine | 1 |
iGMDRD255 | SB225002 | 2 |
iGMDRD474 | Avrainvillamide | 2 |
iGMDRD885 | Compound 110 | 2 |
iGMDRD434 | BMS-536924 | 2 |
Gene in drug-gene network: Network Plot
![](image/gene_network_legends.png)
Gene-drug targets distribution
Gene Structure: PDB
Models in B3GALT6